findmyKOL
Clinical trialNCT05649956RecruitingPhase 2Interventional

Letrozole in Uterine Leiomyosarcoma

SponsorGOG FoundationEnrollment40Uterine Leiomyosarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion

    Aurora, Colorado, United States

    Bradley Corr, MD
    Recruiting
  • Highlands Ranch Hospital

    Highlands Ranch, Colorado, United States

    Bradley Corr, MD
    Recruiting
  • Broward Health Medical Center

    Fort Lauderdale, Florida, United States

    Scott Jordan, MD
    Recruiting
  • Mount Sinai Comprehensive Cancer Center

    Miami Beach, Florida, United States

    Brian Slomovitz, MD
    Recruiting
  • Winship Cancer Institute, Emory Hospital

    Atlanta, Georgia, United States

    Susan Modesitt, MD
    Recruiting
  • Endeavor Health - Kellogg Cancer Center

    Evanston, Illinois, United States

    Endeavor Health - Kellogg Cancer Center Jenkins-Vodel, MD
    Recruiting
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana, United States

    Lisa Landrum, MD
    Recruiting
  • Lsu Health Sciences Center

    New Orleans, Louisiana, United States

    Tara Castellano, MD
    Recruiting
  • Wk Physician Network-Gynecologic Oncology Associates

    Shreveport, Louisiana, United States

    Destin Black, MD
    Recruiting
  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts, United States

    Susan Zweizig, MD
    Recruiting
  • University of Minnesota

    Minneapolis, Minnesota, United States

    Jordan Mattson, MD
    Recruiting
  • Women'S Cancer Center of Nevada

    Las Vegas, Nevada, United States

    Nicola Spirtos, MD
    Recruiting
  • Women'S Cancer Center of Nevada

    Las Vegas, Nevada, United States

    Peter Lim, MD
    Recruiting
  • Atlantic Health System

    Morristown, New Jersey, United States

    Nana Tchabo, MD
    Recruiting
  • Overlook Medical Center

    Summit, New Jersey, United States

    Nana Tchabo, MD
    Recruiting
  • University of New Mexico Comprehensive Cancer Center

    Albuquerque, New Mexico, United States

    Carolyn Muller
    Recruiting
  • East Carolina University Health Medical Center

    Greenville, North Carolina, United States

    Grainger Lanneau, MD
    Recruiting
  • Ohiohealth Arthur G.H. Bing, Md Cancer Center

    Columbus, Ohio, United States

    Aine Clements, MD
    Recruiting
  • Ohiohealth Grant Medical Center

    Columbus, Ohio, United States

    Aine Clements, MD
    Recruiting
  • Ohiohealth Research Institute

    Columbus, Ohio, United States

    Aine Clements, MD
    Recruiting
  • Ohiohealth Riverside Methodist Hospital

    Columbus, Ohio, United States

    Aine Clements, MD
    Recruiting
  • Ohiohealth Marion General Hospital

    Marion, Ohio, United States

    Aine Clements, MD
    Recruiting
  • University of Oklahoma Health Stephenson Cancer Center

    Oklahoma City, Oklahoma, United States

    Laura Holman, MD
    Recruiting
  • Asplundh Cancer Pavilion

    Willow Grove, Pennsylvania, United States

    Tommy Buchanan, MD
    Recruiting
  • Woman and Infants Hospital of Rhode Island

    Providence, Rhode Island, United States

    Matthew Oliver, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Jul 2024
Primary completion
30 Jul 2028
Completion
30 Jul 2029
Last update posted
31 Mar 2026
Registered enrollment
40
Registry id
NCT05649956

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.